Matching slides 22,963
Current window 15,691-15,720
Pages 766
Rows per page 30

Arc

15,691-15,720 of 22,963

filter-aware
70
The slide highlights the third section with a teal background, indicating it is the current or focus topic.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Results1 hit
71
This slide outlines technical parameters for blood collection, likely part of a methodology or process overview.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Results1 hit
72
Includes FDA disclaimer at the bottom.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Results1 hit
73
This slide outlines technical mitigation strategies for blood sample collection issues.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Results1 hit
74
The slide describes the mechanical process of the Theranos nanotainer system.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Results1 hit
75
The slide illustrates the mechanical process of blood collection and sample preparation.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Results1 hit
76
The image shows a Theranos-branded blood collection device (nanotainer).Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Results1 hit
77
Includes FDA disclaimer at the bottom.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Results1 hit
78
Theranos | Investor Conference Presentation Deck | 88 slidesTheranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Results1 hit
79
The slide uses a standard table format to define the parameters of a clinical validation study.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Conclusion1 hit
80
The slide includes a disclaimer that the technology is not FDA cleared.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Conclusion1 hit
81
Passing-Bablok regression used for analysis.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Conclusion1 hit
82
This slide is from a Theranos presentation, likely used to establish the scientific rigor of their testing methodology.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Conclusion1 hit
83
The slide presents clinical validation data for the Theranos miniLab device.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Conclusion1 hit
84
Passing-Bablok regression used for analysis.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Conclusion1 hit
85
Theranos | Investor Conference Presentation Deck | 88 slidesTheranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Conclusion1 hit
86
The slide presents clinical validation data for a diagnostic assay.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Conclusion1 hit
87
Includes disclaimer at the bottom regarding FDA status.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Conclusion1 hit
88
Theranos | Investor Conference Presentation Deck | 88 slidesTheranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Conclusion1 hit
01
Slide 1
Wix | Results Presentation Deck | 16 slidesWix | Results Presentation Deck | 16 slides · Wix
Shareholder letter Investor relations Beat · Setup1 hit
02
The slide uses a two-column layout with narrative on the left and a metrics sidebar on the right.Wix | Results Presentation Deck | 16 slides · Wix
Shareholder letter Investor relations Beat · Setup1 hit
03
The slide uses a split-layout with narrative on the left and a performance table on the right.Wix | Results Presentation Deck | 16 slides · Wix
Shareholder letter Investor relations Beat · EvidenceLoop · So What Cascade1 hit
04
Page 3 of a shareholder letter.Wix | Results Presentation Deck | 16 slides · Wix
Shareholder letter Investor relations Beat · EvidenceLoop · So What Cascade1 hit
05
The slide uses three bar charts to visualize quarterly trends in Collections, GAAP Revenue, and Collections per New Subscription.Wix | Results Presentation Deck | 16 slides · Wix
Shareholder letter Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
06
The slide uses bar charts to compare annual and quarterly performance for key financial ratios.Wix | Results Presentation Deck | 16 slides · Wix
Shareholder letter Investor relations Beat · EvidenceLoop · So What Cascade1 hit
07
The slide highlights the transition to profitability in Q4 2016.Wix | Results Presentation Deck | 16 slides · Wix
Shareholder letter Investor relations Beat · EvidenceLoop · So What Cascade1 hit
08
Includes financial highlights in the opening paragraph and operational metrics in the charts.Wix | Results Presentation Deck | 16 slides · Wix
Shareholder letter Investor relations Beat · DevelopmentLoop · So What Cascade1 hit
09
Page 8 of a shareholder letter.Wix | Results Presentation Deck | 16 slides · Wix
Shareholder letter Investor relations Beat · DevelopmentLoop · So What Cascade1 hit
10
Wix | Results Presentation Deck | 16 slidesWix | Results Presentation Deck | 16 slides · Wix
Shareholder letter Investor relations Beat · DevelopmentLoop · So What Cascade1 hit
11
Wix | Results Presentation Deck | 16 slidesWix | Results Presentation Deck | 16 slides · Wix
Shareholder letter Investor relations Beat · WhatLoop · So What Cascade1 hit